Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC

Yasuto Yoneshima, Satoshi Morita, Masahiko Ando, +17

Journal of Thoracic Oncology

Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer

Masafumi Takeshita, Takaomi Koga, Koichi Takayama, +5

Lung Cancer

Tumor BiologyAurora-b OverexpressionMedicinePathologyBronchial Neoplasm +7

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non–small cell lung cancer harboring <i>EGFR</i> mutations

Kentaro Tanaka, Kaname Nosaki, Kohei Otsubo, +13

Oncotarget

Role and Relevance of TrkB Mutations and Expression in Non–Small Cell Lung Cancer

Taishi Harada, Yasushi Yatabe, Masafumi Takeshita, +4

Clinical Cancer Research

Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study

Kenji Morimoto, Junji Uchino, Takashi Yokoi, +16

OncoImmunology

Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in PC9 Cells

Shuo Wang, Koichi Takayama, Kentaro Tanaka, +5

Journal of Thoracic Oncology

Molecular PharmacologySignal TransductionCell SignalingMedicinePhysiology +6

High podoplanin expression in cancer cells predicts lower incidence of nodal metastasis in patients with lung squamous cell carcinoma

Hanako Suzuki, Mitsuho Onimaru, Takaomi Koga, +5

Pathology - Research and Practice

OncologyHigh Podoplanin ExpressionMedicinePathologyCancer Cells +8

Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Satomi Tanaka, Junji Uchino, Takashi Yokoi, +27

Diagnostics

Pd-l1 TpsImmunologyPathologyImmunotherapyTumor Biology +14

CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non‐small cell lung cancer

Takaomi Koga, Masafumi Takeshita, Tokujiro Yano, +2

International Journal of Cancer

CHFR expression is preferentially impaired in smoking‐related squamous cell carcinoma of the lung, and the diminished expression significantly harms outcomes

Masafumi Takeshita, Takaomi Koga, Koichi Takayama, +6

International Journal of Cancer